Federal Register Notice

Att 2_Federal Register Notice.pdf

Assessing the Impact of Targeted Training and Technical Assistance Efforts on the Implementation of Comprehensive Cancer Control

Federal Register Notice

OMB: 0920-1193

Document [pdf]
Download: pdf | pdf
73110

Federal Register / Vol. 81, No. 205 / Monday, October 24, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of
respondent

Form name

General responder ............................

Responder/Survivor/Advocate (physician).

Postcard for new general responders in NY/NJ to select a clinic.
Physician Request for Certification ..
Denial Letter and Appeal Notification—Enrollment.
Disenrollment Letter and Appeal Notification.
Denial Letter and Appeal Notification—Health Condition Certification.
Decertification Letter and Appeal
Notification.
Denial Letter and Appeal Notification—Treatment Authorization.
WTC Health Program Medical Travel Refund Request.
Form to designate a representative
Form to share member information
Outpatient prescription pharmaceuticals.
Reimbursement Denial Letter and
Appeal Notification.
Petition for the addition of health
conditions.

Total ...........................................

...........................................................

Program Medical Provider ................
Responder (FDNY and General Responder)/Survivor.
Responder (FDNY and General Responder)/Survivor.
Responder (FDNY and General Responder)/Survivor.
Responder (FDNY and General Responder)/Survivor.
Responder (FDNY and General Responder)/Survivor.
Responder (FDNY and General Responder)/Survivor.
Designated Rep Form .......................
HIPAA Release .................................
Pharmacy ..........................................
Program Medical Provider ................

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–25579 Filed 10–21–16; 8:45 am]
BILLING CODE P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–17AW; Docket No. CDC–2016–
0101]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction

sradovich on DSK3GMQ082PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

17:42 Oct 21, 2016

Jkt 241001

Number of
responses
per
respondent

Number of
respondents

1

15/60

619

20,000
45

1
1

30/60
30/60

10,000
23

3

1

30/60

1.5

60

1

90/60

90

5

1

90/60

7.5

26

1

90/60

39

10

1

10/60

2

10
10
150

1
1
261

15/60
15/60
1/60

3
3
653

600

1

30/60

300

60

1

60/60

60

........................

........................

........................

14,052

You may submit comments,
identified by Docket No. CDC–2016–
0101 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE.,
MS–D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change

ADDRESSES:

Frm 00055

Fmt 4703

Total burden
hours

2,475

Act of 1995. This notice invites
comment on the proposed information
collection project entitled ‘‘Assessment
of Targeted Training and Technical
Assistance (TTA) Efforts on the
Implementation of Comprehensive
Cancer Control’’. CDC is requesting to
collect information about TTA offered
under two different cooperative
agreements using case studies, a webbased survey, and in-depth interviews
in order to document how TTA was
provided and identify elements of TTA
administered across both cooperative
agreements that could inform the
development of a viable TTA model for
enhancing future tobacco and cancer
prevention and control efforts.
DATES: Written comments must be
received on or before December 23,
2016.

PO 00000

Average
burden per
response
(in hours)

Sfmt 4703

to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the

E:\FR\FM\24OCN1.SGM

24OCN1

Federal Register / Vol. 81, No. 205 / Monday, October 24, 2016 / Notices
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Assessing the Impact of Targeted
Training and Technical Assistance
Efforts on the Implementation of
Comprehensive Cancer—NEW—
National Center for Chronic Disease
Prevention and Health Promotion,
Centers for Disease Control and
Prevention (CDC).

sradovich on DSK3GMQ082PROD with NOTICES

Background and Brief Description
Cancer is the second leading cause of
death in the United States, and health
care costs for cancer care are expected
to rise to $158 billion by 2020.
Addressing this public health problem
requires primary prevention, early
detection and treatment, support for
cancer survivors, and a reduction in
health disparities. Providing support to
state, tribal, territorial and local
organizations to implement evidencebased strategies has the potential to
impact population-level cancer
outcomes and reduce the burden of
cancer.

VerDate Sep<11>2014

17:42 Oct 21, 2016

Jkt 241001

The Centers for Disease Control and
Prevention’s (CDC) National
Comprehensive Cancer Control Program
(NCCCP) has been a primary funder for
state and community-based cancer
control interventions since its inception
in the late 1990s. The program supports
states and communities in developing a
comprehensive approach to cancer
prevention and control that includes
supporting an infrastructure for state,
local, and population-based
interventions and multi-sectoral
partnerships and coalitions. Currently,
NCCCP supports 65 cancer control
program grantees including programs in
all 50 states, the District of Columbia,
and in a number of tribes, tribal
organizations, and U.S. Associated
Pacific Islands/territories.
In addition, CDC’s Office on Smoking
and Health (OSH) also has worked to
build state health department
infrastructure and capacity to conduct
coordinated comprehensive tobacco
prevention and control activities which
contribute to cancer health outcomes. In
fiscal year 2015, OSH provided funding
to a number of state health departments
and local partners through the National
State-Based Tobacco Control Program
(NSTB) to support the implementation
and evaluation of evidence-based
environmental, policy, and systems
interventions, strategies, and activities
to reduce tobacco use, secondhand
smoke exposure, tobacco-related
disparities and associated disease,
disability, and death.
In striving to build capacity and
maximize the impact of CDC’s funded
programs, CDC has focused on
developing and implementing
innovative programs to enhance TTA
delivered to NCCCP and NSBT grantee
programs. CDC funds 10 programs
under two cooperative agreements—
Consortium of National Networks to
Impact Populations Experiencing
Tobacco-Related and Cancer Health
Disparities (DP13–1314) and the
National Support to Enhance
Implementation of Comprehensive
Cancer Control Activities (DP13–1315).
These cooperative agreements provide
funding to organizations to provide TTA
to state NCCCP and NSBT grantees to
support local implementation of highimpact public health strategies. DP13–
1314 awardees are charged with
building the capacity of NCCCP and
NSBT grantees through the
administration of a national network to
reduce the burden of cancer- and
tobacco-related health disparities among
vulnerable populations; DP13–1315
awardees are charged with delivering
TTA to NCCCP programs and partners
to enhance and facilitate local

PO 00000

Frm 00056

Fmt 4703

Sfmt 4703

73111

implementation of comprehensive
cancer control (CCC) activities; policy,
systems and environmental change
strategies; effective public health
partnership building; and promotion of
CCC program successes and leverage
additional resources for cancer control
and prevention. These two TTA models
aim to impact both short- and long-term
outcomes on the awardee, NCCCP
program, and population levels.
CDC proposes to conduct an
assessment of the DP13–1314 and
DP13–1315 cooperative agreements to:
(1) Increase CDC’s understanding of the
TTA provided to NCCCP and NSTB
grantees across both cooperative
agreements, (2) help identify the extent
to which core elements of the TTA were
administered, and (3) determine the
elements of TTA across both
cooperative agreements that show
promise for improving NCCCP and
NSTB capacity. There are no other data
collection efforts currently underway to
assess implementation of the two TTA
models or their perceived effectiveness
among awardee programs.
This information collection request
will involve three complementary data
collection efforts: (1) Case studies of
DP13–1314 and DP13–1315 awardees
(consisting of interviews with DP13–
1314 and DP13–1315 program
managers/directors, evaluators, and
partners); (2) a cross-sectional webbased survey administered to NCCCP
and NSBT program directors, coalition
members, and partners; and (3) in-depth
interviews with NCCCP and NSBT
program directors, staff, coalition
members, and partners who received a
high volume of TTA from one or more
of the DP13–1314 and DP13–1315
awardees. The case studies will be used
to explore how DP13–1314 and DP13–
1315 awardees are implementing their
respective cooperative agreements and
administering TTA to NCCCP and NSBT
grantees; the factors that affect the
implementation of specific TTA
components; and the extent to which
each cooperative agreement was able to
achieve planned short-term outcomes.
The web-based survey will inform
CDC’s understanding of the reach of
DP13–1314 and DP13–1315 TTA efforts;
elicit information from NCCCP and/or
NSBT programs and coalitions about the
TTA received, including type, dosage,
frequency and format; and assess the
perceptions of the effectiveness of the
TTA provided in building capacity to
achieve intended outcomes. The indepth interviews with ‘‘high-volume’’
TTA users will facilitate an in-depth
exploration of the type and quality of
TTA activities received; perceived
quality of TTA and its contributions to

E:\FR\FM\24OCN1.SGM

24OCN1

73112

Federal Register / Vol. 81, No. 205 / Monday, October 24, 2016 / Notices

NCCCP and NSBT grantee program
implementation, and achievement of
CDC priorities and goals.
CDC will use findings from the
assessment to inform development of
future TTA efforts that utilize the core

elements across the two models to more
effectively and efficiently support
NCCCP’s partner organizations.
CDC seeks a two-year approval to
collect the required information.
Participation is voluntary and

respondents will not receive incentives
for participation. There are no costs to
respondents other than their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

DP13–1314 and DP13–1315 Awardee Organizations.
DP13–1314 Program Directors/Managers.

Worksheet for Identifying Case
Study Interviewees.
Case Study Interview Guide for
DP13–1314 Program Managers.
Case Study Follow-Up Interview
Guide for DP13–1314 Program
Managers.
Case Study Interview Guide for
DP1–1315 Program Managers.
Case Study Follow-Up Interview
Guide for DP1–1315 Program
Managers.
Case Study Interview Guide for
DP1–1314 Evaluators.
Case Study Interview Guide for
DP1–1315 Evaluators.
Case Study Interview Guide for
DP1–1314 Partners.
Case Study Interview Guide for
DP1–1315 Partners.
Survey ..............................................

NSBT Program DirecPartners, and Coalition

Total ...........................................

DP13–1315 Program Directors/Managers.

DP13–1314 Evaluators .....................
DP13–1315 Evaluators .....................
DP13–1314 Partners ........................
DP13–1315 Partners ........................
NCCCP and
tors, Staff,
Members.
NCCCP and
tors, Staff,
Members.

NSBT Program DirecPartners, and Coalition

60/60

10

16

1

90/60

24

16

1

60/60

16

4

1

90/60

6

4

1

60/60

4

16

1

60/60

16

4

1

60/60

4

32

1

60/60

32

8

1

60/60

8

1560

1

15/60

390

TTA Recipient Interview Guide ........

10

1

30/60

5

...........................................................

........................

........................

........................

515

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–17–16AVC]

Agency Forms Undergoing Paperwork
Reduction Act Review
sradovich on DSK3GMQ082PROD with NOTICES

Total burden
(in hours)

1

[FR Doc. 2016–25671 Filed 10–21–16; 8:45 am]

The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is

17:42 Oct 21, 2016

Average
burden per
response
(in hours)

10

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.

VerDate Sep<11>2014

Number of
responses per
respondent

Number of
respondents

Type of respondents

Jkt 241001

published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of

PO 00000

Frm 00057

Fmt 4703

Sfmt 4703

responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.
Proposed Project
CDC/ATSDR Formative Research and
Tool Development—New — Office of
the Director, Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention requests approval for a new
generic information collection plan
entitled CDC/ATSDR Formative
Research and Tool Development. This

E:\FR\FM\24OCN1.SGM

24OCN1


File Typeapplication/pdf
File Modified2016-10-21
File Created2016-10-22

© 2024 OMB.report | Privacy Policy